View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Mogamulizumab 1, cutaneous T-cell lymphoma, cycle 1
Protocol-ID: 1397 V1.0 (Mini), MOGA1, CTCL, C1Indication(s)
- NHL, T-Cell Type, Cutaneous, Unspecified; ICD-10 C84.8
- NHL, T-Cell Type, Mycosis Fungoides; ICD-10 C84.0
- NHL, T-Cell Type, Sézary Syndrome; ICD-10 C84.1
Links
- Mogamulizumab (poteligeo) [EMA EPAR]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 17.10.2019